Kathleen M. Gustafson

Prof. Kathleen M. Gustafson

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
SCSusan Elaine Carlson
Susan Elaine Carlson
JCJohn Colombo
John Colombo
BGByron J Gajewski
Byron J Gajewski
KGKathleen M. Gustafson
Kathleen M. Gustafson
DMDavid Mundy
David Mundy
DSD Jill Shaddy
D Jill Shaddy
Background: Observational studies associate higher intakes of n−3 (omega-3) long-chain polyunsaturated fatty acids (LCPUFAs) during pregnancy with hig

1 April 2010 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
EBEileen E Birch
Eileen E Birch
SCSusan E Carlson
Susan E Carlson
DHDennis R Hoffman
Dennis R Hoffman
KGKathleen M. Gustafson
Kathleen M. Gustafson
VFValeria Ln Fu
Valeria Ln Fu
DDDeborah A Diersen-Schade
Deborah A Diersen-Schade
Background: The range of human milk docosahexaenoic acid (DHA) concentrations worldwide is much broader than the range explored in randomized clinical trials to date.

1 August 2013 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
JCJohn Colombo
John Colombo
SCSusan Elaine Carlson
Susan Elaine Carlson
CCCarol Cheatham
Carol Cheatham
DSD Jill Shaddy
D Jill Shaddy
EKElizabeth H Kerling
Elizabeth H Kerling
CBCaitlin Brez
Caitlin Brez
Background: The effect of long-chain polyunsaturated fatty acid (LCPUFA) intake on cognitive development is controversial. Most randomized trials hav

1 April 2010 in Early Human Development
Verified
Journal Article
Closed access
LMLinda E. May
Linda E. May
AGAlan Glaros
Alan Glaros
HYHung-Wen Yeh
Hung-Wen Yeh
JCJames F. Clapp
James F. Clapp
KGKathleen M. Gustafson
Kathleen M. Gustafson

16 December 2020 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Hannes DevosHannes Devos
Hannes Devos
KGKathleen M. Gustafson
Kathleen M. Gustafson
PAPedram Ahmnadnezhad
Pedram Ahmnadnezhad
KLKe Liao
Ke Liao
JMJonathan D. Mahnken
Jonathan D. Mahnken
JBJeffrey M. Burns
Jeffrey M. Burns
Cognitive workload is increasingly recognized as an important determinant of performance in cognitive tests and daily life activities. Cognitive workload is a measure of physical and mental effort allocation to a task, which can be determined through self-report or physiological measures. However, the reliability and validity of these measures have not been established in older adults with a wide range of cognitive ability. The aim of this study was to establish the test–retest reliability of the National Aeronautics and Space Administration Task Load Index (NASA-TLX) and Index of Cognitive Activity (ICA), extracted from pupillary size. The convergent validity of these measures against event-related potentials (ERPs) was also investigated. A total of 38 individuals with scores on the Montreal Cognitive Assessment ranging between 17 and 30 completed a working memory test (n-back) with three levels of difficulty at baseline and at a two-week follow-up. The intraclass correlation coefficients (ICC) values of the NASA-TLX ranged between 0.71 and 0.81, demonstrating good to excellent reliability. The mean ICA scores showed fair to good reliability, with ICCs ranging between 0.56 and 0.73. The mean ICA and NASA-TLX scores showed significant and moderate correlations (Pearson’s r ranging between 0.30 and 0.33) with the third positive peak of the ERP at the midline channels. We conclude that ICA and NASA-TLX are reliable measures of cognitive workload in older adults. Further research is needed in dissecting the subjective and objective constructs of cognitive workload.

1 October 2011 in Pediatric Research
Verified
Journal Article
Open access
PDF file
JCJohn Colombo
John Colombo
SCSusan Elaine Carlson
Susan Elaine Carlson
CCCarol Cheatham
Carol Cheatham
KGKathleen M. Gustafson
Kathleen M. Gustafson
AKAmy Kepler
Amy Kepler
TDTasha Doty
Tasha Doty
A double-blind, randomized, controlled, parallel-group prospective trial was conducted to determine whether a dose-response existed for four different levels of docosahexaenoic acid (DHA) supplementation on the cognitive performance of infants. A total of 122 term infants were fed one of four different formulas varying in their DHA composition (0.00, 0.32, 0.64, and 0.96% of total fatty acids as DHA) from birth to 12 mo. The three DHA-supplemented formulas also contained 0.64% of total fatty acids as arachidonic acid (ARA, 20:4n-6). Infants were tested at 4, 6, and 9 mo of age on a visual habituation protocol that yielded both behavioral and psychophysiological indices of attention. Infants in all DHA+ARA-supplemented conditions had lower heart rates than those in the unsupplemented condition; there was no dose-response for this effect. The distribution of time that infants spent in different phases of attention (a cognitive index derived from the convergence of behavioral and cardiac responses) varied as a function of dosage. Infants supplemented at the two lower DHA doses spent proportionately more time engaged in active stimulus processing than infants fed the unsupplemented formula, whereas infants fed the highest dose were intermediate and did not differ from any other group.